Caprock Gastro Research was established with the aim of facilitating access to innovative medications. This organization offers patients suffering from specific gastrointestinal conditions the opportunity to participate in clinical drug trials. These trials, conducted under the stringent regulations of the Food and Drug Administration (FDA), are funded by the pharmaceutical companies developing the drugs. At Caprock Gastro Research, patients are under the careful supervision of healthcare professionals and are monitored according to the specific rules of each clinical trial. Currently, the focus is on recruiting patients diagnosed with Ulcerative Colitis or Crohn’s disease.

Inflammatory bowel disease (IBD) is a disease that represents a group of intestinal disorders that cause prolonged inflammation of the digestive tract. The digestive tract consists of the mouth, esophagus, stomach, small intestine and large intestine. Inflammation in the digestive tract can affect the breaking down of food, extracting nutrients and removing any unusable material and waste products. IBD can cause symptoms that can disrupt a person’s life and become life-threatening.

ULCERATIVE COLITIS (UC)

UC causes chronic inflammation of the large intestines, or the colon. The lining of the colon develops tiny open sores, or ulcers. Symptoms of UC are:

• Abdominal pain

• Loose stools

• Bloody stools

• Urgency of bowel movement

• Fatigue

• Weight loss

• Malnutrition